Health experts have urged Australians not to be concerned about the safety and progress of the Oxford coronavirus vaccine after phase three trials were halted.
WATCH: Deputy Chief Medical Officer says AstraZeneca illness 'needs to be investigated'
“With many thousands of people getting the vaccine, medical events can happen that have nothing to do with a vaccine.”Dr Coatsworth said the pausing of the event was “quite normal” when it comes to vaccine development. Workers of the mAbxience laboratory, chosen by AstraZeneca for the production in Latin America of the Oxford vaccine against COVID-19 carry out testing.RMIT Professor Magdalena Plebanski, a respected vaccine researcher, said the pause is far from unusual when it comes to phase three trials of vaccine candidates.
The voluntary pause means new participants are not being immunised with the dose, but participants who have already been vaccinated will continue to be monitored. The Australian government has said the first doses of the vaccine could be distributed to the public as soon as January and February next year.“There will be a delay while it's being investigated, but I would not say this would be a major delay,” she said.Nine COVID-19 vaccine developers in 'historic pledge' to uphold scientific integrity
The federal government has also signed agreements to secure doses of a vaccine candidate currently being developed by the University of Queensland and CSL, which is currently in phase two trials.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oxford coronavirus vaccine trial on hold over 'potentially unexplained illness'The Oxford University coronavirus vaccine trial is halted in what drug maker AstraZeneca describes as a 'routine' action taken when there is a potentially unexplained illness among participants.
Read more »
Trials of Oxford COVID-19 vaccine on hold after participant suffers adverse reactionAn Oxford University trial of a coronavirus vaccine has been put on hold due to safety concerns after a trial participant had a serious adverse reaction, in what AstraZeneca referred to as a 'routine action'.
Read more »
Reports of adverse reaction to Oxford COVID-19 vaccineJUST IN: Deputy Chief Medical Officer Nick Coatsworth said reports the Oxford University COVID-19 vaccine had recorded a major setback in trials needed to be investigated. 9News
Read more »
Oxford coronavirus vaccine trial on hold over 'potentially unexplained illness'The Oxford University coronavirus vaccine trial is halted in what drug maker AstraZeneca describes as a 'routine' action taken when there is a potentially unexplained illness among participants.
Read more »
Donald Trump slams Kamala Harris over 'reckless anti-vaccine rhetoric'US President Donald Trump on Monday again hinted a coronavirus vaccine will be available before November's election, as he accused his Democratic rivals for the White House of undermining public confidence in the immunisation.
Read more »
Nine COVID-19 vaccine developers in 'historic pledge' to uphold scientific integrityThe pledge was made following growing concerns about a rushed approval of a coronavirus vaccine after US President Donald Trump predicted a vaccine could be available by the end of the year.
Read more »